CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 
 

VIR's Income from Cont. Operations Growth by Quarter and Year

Vir Biotechnology Inc 's Income from Cont. Operations results by quarter and year




VIR Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 525.25 -105.65 48.31
III Quarter September 175.31 110.43 -84.61 -48.31
II Quarter June -76.49 61.81 -31.17 0.00
I Quarter March 518.62 -168.91 -77.24 0.00
FY   617.44 528.58 -298.67 0.00



VIR Income from Cont. Operations third quarter 2022 Y/Y Growth Comment
Vir Biotechnology Inc achieved in the third quarter 2022, above Company average Income from Cont. Operations rise of 58.75% year on year, to $ 175.31 millions.

Looking into third quarter 2022 results within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher Income from Cont. Operations growth. While Vir Biotechnology Inc ' s Income from Cont. Operations jump of 58.75% ranks overall at the positon no. 483 in the third quarter 2022.




VIR Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September 58.75 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Vir Biotechnology Inc 's third quarter 2022 Income from Cont. Operations $ 175.31 millions VIR's Income Statement
Vir Biotechnology Inc 's third quarter 2021 Income from Cont. Operations $ 110.43 millions Quarterly VIR's Income Statement
New: More VIR's historic Income from Cont. Operations Growth >>


VIR Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 375.64 % - -
III Quarter September - 78.66 % - -
II Quarter June - - - -
I Quarter March -1.26 % - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #11
Healthcare Sector #39
Overall #483

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
130.07 % 41.57 % -11.37 %
(Mar 31 2022)   (Jun 30 2022)
Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #11
Healthcare Sector #39
Overall #483
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
130.07 % 41.57 % -11.37 %
(Mar 31 2022)   (Jun 30 2022)

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Vir Biotechnology Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
375.65 % 151.01 % -1.26 %
(Dec 31 2021)  


VIR's III. Quarter Q/Q Income from Cont. Operations Comment
III. Quarter 2022Seasonal Vir Biotechnology Inc in the circumstances loss from continued operations of $ 175.31 millionsSeasonal circumstances seem to have added to Vir Biotechnology Inc 's rebound to positive trends, as VIR postIncome from Cont. Operations of $ 175.31 millions in the III. Quarter 2022 emanate loss from continued operations-76.49 millions in the second quarter. Vir Biotechnology Inc announced in the III. Quarter 2022 Income from Cont. Operations of $ 175.31 millions compare to loss from continued operations recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Vir Biotechnology Inc achieved highest sequential Income from Cont. Operations growth. While Vir Biotechnology Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 0.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
375.65 % 151.01 % -1.26 %
(Dec 31 2021)  


VIR's III. Quarter Q/Q Income from Cont. Operations Comment
III. Quarter 2022Cyclical Vir Biotechnology Inc in the influence loss from continued operations of $ 175.31 millionsCyclical influence appear to have added to Vir Biotechnology Inc 's rebound to positive trends, as VIR clinchesIncome from Cont. Operations of $ 175.31 millions in the III. Quarter 2022 emerging from loss from continued operations-76.49 millions in the second quarter. Vir Biotechnology Inc announced in the III. Quarter 2022 Income from Cont. Operations of $ 175.31 millions compare to loss from continued operations recorded in previos quarter.

Within Biotechnology & Pharmaceuticals industry Vir Biotechnology Inc achieved highest sequential Income from Cont. Operations growth. While Vir Biotechnology Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 0.


Vir Biotechnology Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ 1,142.69 $ 1,077.81 $ 1,216.12 $ 528.58 $ -102.32
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking